
Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015
Author(s) -
Joungyoun Kim,
Yoon-Jong Bae,
Jae-woo Lee,
Yeseul Kim,
Yonghwan Kim,
Hyo-Sun You,
Hyeong-Seop Kim,
EunA Choi,
Ye-Eun Han,
Hee-Taik Kang
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025045
Subject(s) - medicine , metformin , diabetes mellitus , national health insurance , cancer , environmental health , health insurance , gerontology , family medicine , health care , endocrinology , economic growth , population , economics